Dr. Puja Shweta Venkat, MD

Dr. Venkat practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Venkat's NPI, 1144587742, was assigned on April 19, 2012. Dr. Venkat graduated from University of Toledo College of Medicine and Life Sciences in 2012. Dr. Venkat holds Florida license TRN18967.

Dr. Venkat's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Venkat's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Venkat is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group (UCLA Health). Dmand AI also links Dr. Venkat to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkat practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Venkat's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Venkat is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Venkat's licenses on file in 3 states: Florida, California and Michigan.

Dmand AI lists cancer radiation-upper GI, cervical cancer radiation, head & neck cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Venkat treats.

CMS data shows 1,494 Medicare services from Dr. Venkat across 24 procedure codes in 2024, for 224 Medicare patients. Medicare paid $157,754 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Dr. Venkat in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkat's median patient age at 68, with 75% women.

In 2024, Dr. Venkat wrote 92 Medicare Part D claims for 58 patients. 78% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $450 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Venkat for performance year 2024, reported as part of a group. Dr. Venkat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Venkat as offering telehealth. CMS counts 19 procedures of colonoscopy by Dr. Venkat, more than 47% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Venkat, published from 2015 to 2021. 2018 was the busiest year, with 2. Dr. Venkat's most frequent co-authors are Jessica M. Frakes, Sarah Elizabeth Hoffe, MD and Jose Mario Pimiento, MD.

CMS Open Payments shows 32 general payments to Dr. Venkat from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $2,431.

Dr. Venkat graduated from University of Toledo College of Medicine and Life Sciences in 2012.

Dr. Venkat is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.